B cells are an important pathogenic component of autoimmunity, but our current knowledge of the phenotype of pathogenic B cells in these diseases is limited. While most B cells express only one type of antibody and are specific for one antigen, rare B cells co-expressing two different antibodies (i.e., dual-reactive B cells) exis in mice and are present in humans. Our goal is to understand whether dual-reactive B cells represent a relevant B cell subset in autoimmunity and to characterize their biology. Our novel findings demonstrate that autoimmune mice generate dual-reactive B cells more frequently than nonautoimmune mice. The majority of these cells react with self-antigens and they are highly enriched in the antigen-activated B cell subsets of autoimmune mice. Furthermore, we have identified a molecular pathway that drive the differentiation of nonautoreactive immature B cells into transitional and mature B cells and that, we propose, is also used for the generation of B cells that co-express autoreactive and nonautoreactive antibodies. In the previous grant cycle we laid the foundation for the proposed research by generating the data on which we base our new hypotheses and by creating the mutant mice and methodologies with which to follow development and selection of dual-reactive B cells in autoimmune and nonautoimmune mice. We believe, therefore, that we are uniquely poised to carry out the proposed studies. Our hypothesis is that dual-reactive B cells evade mechanisms of central and peripheral B cell tolerance to become an important component of autoimmune diseases. The goal of the proposed research is to deepen our understanding of the relationship between dual-reactive B cells and autoimmunity in mice. We will investigate the mechanisms that cause increased generation, selection and enrichment of dual-reactive B cells in autoimmune-prone mice and whether these B cells contribute to the development of autoimmunity or are rather a diagnostic marker. We will also translate our mouse studies by examining the prevalence of dual-reactive B cells in humans with autoimmunity. To achieve our goals we will develop the following specific aims: 1) to determine whether activation of Ras and/or of tonic BCR signaling inhibits negative selection and promotes positive selection of autoreactive immature B cells;2) to establish the B cell-extrinsic signals that drive the increased activation and positive selection o dual-? B cells in autoimmune mice;3) to determine whether dual-reactive B cells contribute to autoimmunity in mice and are enriched in autoimmune patients. The studies proposed will establish dual-reactive B cells as a diagnostic and/or pathogenic B cell subset in autoimmunity and will be of value for the development of methods that identify and target these B cells while preserving those that fight infections. Overall, these studies are important for understanding B cell-mediated mechanisms of autoimmune development and to uncover novel targets for therapeutic intervention.

Public Health Relevance

The role of B cells in autoimmune diseases has become increasingly evident. However, our current knowledge of the types of B cells that are important in these diseases is still limited. More studies are needed to further characterize disease-mediating B cells and uncover their unique characteristics and mode of action. Our studies will investigate a type of B cells that is increased in models of autoimmunity and that causes production of autoantibodies, a relevant component of this disease. These studies might lead to the recognition of a novel diagnostic and/or pathogenic cell component of autoimmunity and to the development of new specific therapies that target only pathogenic B cells leaving intact those B cells that fight off infections.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Peyman, John A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Jewish Health
United States
Zip Code
Hobeika, Elias; Levit-Zerdoun, Ella; Anastasopoulou, Vasiliki et al. (2015) CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk. EMBO J 34:925-39
Hu, Jiancheng; Oda, Shannon K; Shotts, Kristin et al. (2014) Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol 193:85-95
Teodorovic, Lenka S; Babolin, Chiara; Rowland, Sarah L et al. (2014) Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies. Proc Natl Acad Sci U S A 111:E2797-806
Pelanda, Roberta (2014) Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity? Curr Opin Immunol 27:53-9
Swanson, Cristina L; Pelanda, Roberta; Torres, Raul M (2013) Division of labor during primary humoral immunity. Immunol Res 55:277-86
Rowland, Sarah L; Tuttle, Kathryn; Torres, Raul M et al. (2013) Antigen and cytokine receptor signals guide the development of the naive mature B cell repertoire. Immunol Res 55:231-40
Feldman, Amy G; Tucker, Rebecca M; Fenner, Erika K et al. (2013) B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia. PLoS One 8:e73644
Fuquay, Richard; Renner, Brandon; Kulik, Liudmila et al. (2013) Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol 24:1063-72
Pujanauski, Lindsey M; Janoff, Edward N; McCarter, Martin D et al. (2013) Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A 110:1422-7
Larson, Jennifer D; Thurman, Joshua M; Rubtsov, Anatoly V et al. (2012) Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. Proc Natl Acad Sci U S A 109:E1092-100

Showing the most recent 10 out of 22 publications